Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Radnostix, Inc. | Idaho Falls, ID, United States | Makes it | Serious problems, FDA actionApr 25, 2025 · 7 inspections, 3 with FDA action |
Recalls
- Feb 19, 2026 · Class III · Radnostix
Failed Tablet/Capsule Specifications
Lots: Lot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027 - Jan 26, 2026 · Class II · Radnostix
Presence of Particulate Matter: Due to production issues
Lots: Batch I012626R-01, Exp 02/09/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Iodide Ion I-131: every company that makes it
- Form
- kit, oral
- Strength
- 1000 mCi
- Approval
- ANDA ANDA209166
- On the market since
- Mar 16, 2020
- Package NDCs
69208-000-0069208-003-1569208-003-2569208-003-35- Official label
- DailyMed (National Library of Medicine), updated Jan 23, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?